EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment

Xin Huang iD, Junfeng Hao iD, Shuo Wang iD, Botian Deng iD, Peng Wang iD, Qiuyu Zhao iD, Hongbo Liu iD, Jiahe Wang iD

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2534673123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xin Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110022, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Hepatic Stellate Cells, Macrophages, RNA, Messenger. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, marked by an abnormal buildup of extracellular matrix (ECM), poses a major health threat. Myofibroblasts, predominantly derived from hepatic stellate cells (HSCs) and portal fibroblasts, are the primary drivers of ECM synthesis. Fibroblast activation protein (FAP), highly expressed by activated HSCs, is a pivotal player in the pathogenesis of liver fibrosis. Delineating the mechanisms underlying HSC activation and devising strategies to curb their hyperactivity are paramount for the management and prevention of liver fibrosis. In this study, we explored a pioneering therapeutic approach leveraging CD163 antibody-conjugated liposomal nanoparticles (LNPs) encapsulating FAP-specific chimeric antigen receptor macrophage (CAR-M) mRNA (αCD163/LNP-FAPCAR). These LNPs are designed to selectively transduce liver macrophages, facilitating the in situ generation of FAP-specific CAR-modified macrophages (FAPCAR-M). Our findings revealed that these LNPs efficiently transduced macrophages, augmenting their phagocytic capabilities toward target cells. This resulted in a significant reduction of ECM and a concomitant enhancement of liver fibrosis resolution. The overarching goal is to precisely target and neutralize hyperactive fibroblasts, offering a promising avenue for treating liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisHepatic Stellate CellsMacrophagesRNA, MessengerNanoparticlesAnimalsFibroblast Activation Protein AlphaReceptors, Cell SurfaceMiceMembrane ProteinsAntigens, CDCD163 AntigenLiposomesAntigens, Differentiation, MyelomonocyticGelatinasesEndopeptidasesCellular MicroenvironmentExtracellular MatrixHumansMale

Stichwörter der Autor:innen

ECMFAP-CARLNPsliver fibrosismacrophages

Substanzen

Fibroblast Activation Protein AlphaReceptors, Cell SurfaceMembrane ProteinsAntigens, CDRNA, MessengerCD163 AntigenLiposomesAntigens, Differentiation, MyelomonocyticGelatinasesEndopeptidases

Autor:innen und Institutionen

  • Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Department of Nephrology, and Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
  • Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Department of Key Laboratory of Ministry of Education for Traditional Chinese Medicine Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China.
  • Third Department of Respiratory, Shengjing Hospital of China Medical University, Shenyang 110022, China.

ORCID-Profile: Xin Huang, Junfeng Hao, Shuo Wang, Botian Deng, Peng Wang, Qiuyu Zhao, Hongbo Liu, Jiahe Wang

Zitieren

APA

Huang, X., Hao, J., Wang, S., Deng, B., Wang, P., Zhao, Q., Liu, H., & Wang, J. (2026). mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2534673123

Vancouver

Huang X, Hao J, Wang S, Deng B, Wang P, Zhao Q, et al. mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2534673123

BibTeX
@article{Huang2026,
  author = {Huang, Xin and Hao, Junfeng and Wang, Shuo and Deng, Botian and Wang, Peng and Zhao, Qiuyu and Liu, Hongbo and Wang, Jiahe},
  title = {mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2534673123}
}
Kostenlos starten →